上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2014年
13期
31-33
,共3页
抗菌药物%骨科%临床路径
抗菌藥物%骨科%臨床路徑
항균약물%골과%림상로경
department of orthopedics clinical path%prophylactic antibiotics%the incidence of infection
目的:探讨骨科临床路径实施对Ⅰ类切口手术预防性抗菌药物使用的影响,为临床Ⅰ类切口手术预防性抗菌药物的使用和管理提供依据。方法:以原卫生部制定的骨科临床路径为基础,结合医院自身的实际情况设计相应临床路径,回顾性调查分析实施临床路径前后患者抗菌药物使用情况。结果:实施临床路径后Ⅰ类切口手术预防性抗菌药物使用的比例从76.49%降低到62.72%,术后感染率没有明显区别,分别为1.04%和0.96%。临床路径组手术后平均用药时间从2.5 d减少到1.1 d。结论:临床路径能够规范Ⅰ类切口预防性抗菌药物的使用,对促进安全合理使用Ⅰ类切口预防性抗菌药物起到促进作用。
目的:探討骨科臨床路徑實施對Ⅰ類切口手術預防性抗菌藥物使用的影響,為臨床Ⅰ類切口手術預防性抗菌藥物的使用和管理提供依據。方法:以原衛生部製定的骨科臨床路徑為基礎,結閤醫院自身的實際情況設計相應臨床路徑,迴顧性調查分析實施臨床路徑前後患者抗菌藥物使用情況。結果:實施臨床路徑後Ⅰ類切口手術預防性抗菌藥物使用的比例從76.49%降低到62.72%,術後感染率沒有明顯區彆,分彆為1.04%和0.96%。臨床路徑組手術後平均用藥時間從2.5 d減少到1.1 d。結論:臨床路徑能夠規範Ⅰ類切口預防性抗菌藥物的使用,對促進安全閤理使用Ⅰ類切口預防性抗菌藥物起到促進作用。
목적:탐토골과림상로경실시대Ⅰ류절구수술예방성항균약물사용적영향,위림상Ⅰ류절구수술예방성항균약물적사용화관리제공의거。방법:이원위생부제정적골과림상로경위기출,결합의원자신적실제정황설계상응림상로경,회고성조사분석실시림상로경전후환자항균약물사용정황。결과:실시림상로경후Ⅰ류절구수술예방성항균약물사용적비례종76.49%강저도62.72%,술후감염솔몰유명현구별,분별위1.04%화0.96%。림상로경조수술후평균용약시간종2.5 d감소도1.1 d。결론:림상로경능구규범Ⅰ류절구예방성항균약물적사용,대촉진안전합리사용Ⅰ류절구예방성항균약물기도촉진작용。
Objective: To probe the inlfuence of the implementation of clinical department of orthopedics path (CP) on the preventive application of antibiotic in the ifrst-class incision operation so as to provide a basis for the use and management of prophylactic antimicrobial agents in the first-class clinical incision operation.Methods: The use of antibacterial agents was retrospectively investigated and analyzed before and after the implementation of CP by designing corresponding clinical path based on the CP drawn up by the Ministry of Health and the actual situation of our hospital.Results: After implementing the clinical pathway, the ratio of the application of prophylactic antimicrobial agents in the ifrst-class incision operation was significantly reduced from 76.49% to 62.72% (P<0.05), and there was no significant difference in the rates of postoperative infection, which were 1.04% and 0.96%, respectively. The average medication time was signiifcantly decreased from 2.5 days to 1.1 days (P<0.05).Conclusion: The clinical pathway can regulate the preventive application of antibiotic in the ifrst-class incision operation and promote the rational and safe use of prophylactic antibiotics in the ifrst-class incision operation.